title: Has demand for clinical trial participants outpaced supply?
authors.forename: Jennifer T
authors.initials: JT
authors.lastname: Tam-McDevitt
authors.forename: Lodovico
authors.initials: L
authors.lastname: Balducci
authors.forename: Robert S
authors.initials: RS
authors.lastname: Hauser
authors.forename: Daniel
authors.initials: D
authors.lastname: Gura
authors.forename: Aram
authors.initials: A
authors.lastname: Paraghamian
authors.forename: Heidi
authors.initials: H
authors.lastname: Thomas
authors.forename: Stuart M
authors.initials: SM
authors.lastname: Lichtman
mesh_terms: D001943:Breast Neoplasms / Q000628:therapy; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy; D008297:Male; D009369:Neoplasms / Q000188:drug therapy* / Q000628:therapy; D018579:Patient Selection; D011471:Prostatic Neoplasms / Q000628:therapy; D035842:Research Subjects / Q000600:supply & distribution*; D014481:United States